Premium
Denali Therapeutics Inc (DNLI)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates ... Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 2.17 | 10.8175473579 | 20.06 | 22.29 | 20.05 | 699160 | 21.3185436 | CS |
| 4 | -0.81 | -3.515625 | 23.04 | 24.345 | 20.05 | 853212 | 22.36478442 | CS |
| 12 | -3.04 | -12.030075188 | 25.27 | 26.18 | 18.52 | 903818 | 22.01485575 | CS |
| 26 | -0.73 | -3.17944250871 | 22.96 | 33.33 | 18.52 | 886250 | 25.02005535 | CS |
| 52 | 5.67 | 34.2391304348 | 16.56 | 33.33 | 14.56 | 1031941 | 22.38169547 | CS |
| 156 | -10.4 | -31.8725099602 | 32.63 | 39.43 | 14.56 | 840645 | 24.4783644 | CS |
| 260 | -3.89 | -14.8928024502 | 26.12 | 93.94 | 12.39 | 740087 | 32.0140845 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
